CA1171413A - Synthetic method and intermediate for piroxicam - Google Patents
Synthetic method and intermediate for piroxicamInfo
- Publication number
- CA1171413A CA1171413A CA000386690A CA386690A CA1171413A CA 1171413 A CA1171413 A CA 1171413A CA 000386690 A CA000386690 A CA 000386690A CA 386690 A CA386690 A CA 386690A CA 1171413 A CA1171413 A CA 1171413A
- Authority
- CA
- Canada
- Prior art keywords
- piroxicam
- ester
- hydroxy
- methyl
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 title claims abstract description 13
- 229960002702 piroxicam Drugs 0.000 title claims abstract description 13
- 238000010189 synthetic method Methods 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 claims description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000008096 xylene Substances 0.000 claims description 6
- 239000006227 byproduct Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract description 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 2
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- VJGMQUWZFATDFA-UHFFFAOYSA-N 2-methoxyethyl 4-hydroxy-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxylate Chemical compound C1=CC=C2S(=O)(=O)N(C)C(C(=O)OCCOC)=C(O)C2=C1 VJGMQUWZFATDFA-UHFFFAOYSA-N 0.000 abstract 1
- PGBYMPJXTSIZEC-UHFFFAOYSA-N 4-hydroxy-2-methyl-n-pyridin-2-yl-1,2-benzothiazine-3-carboxamide Chemical compound CN1SC2=CC=CC=C2C(O)=C1C(=O)NC1=CC=CC=N1 PGBYMPJXTSIZEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000014571 nuts Nutrition 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- -1 methyl halide Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- XJRIDJAGAYGJCK-UHFFFAOYSA-N (1-acetyl-5-bromoindol-3-yl) acetate Chemical compound C1=C(Br)C=C2C(OC(=O)C)=CN(C(C)=O)C2=C1 XJRIDJAGAYGJCK-UHFFFAOYSA-N 0.000 description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- GHPYJLCQYMAXGG-WCCKRBBISA-N (2R)-2-amino-3-(2-boronoethylsulfanyl)propanoic acid hydrochloride Chemical compound Cl.N[C@@H](CSCCB(O)O)C(O)=O GHPYJLCQYMAXGG-WCCKRBBISA-N 0.000 description 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- ZTVIKZXZYLEVOL-DGKWVBSXSA-N 2-hydroxy-2-phenylacetic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester Chemical group C([C@H]1CC[C@@H](C2)N1C)C2OC(=O)C(O)C1=CC=CC=C1 ZTVIKZXZYLEVOL-DGKWVBSXSA-N 0.000 description 1
- CUIGSPBMMQWNLR-UHFFFAOYSA-N 2-isocyanatopyridine Chemical compound O=C=NC1=CC=CC=N1 CUIGSPBMMQWNLR-UHFFFAOYSA-N 0.000 description 1
- ASQUQUOEFDHYGP-UHFFFAOYSA-N 2-methoxyethanolate Chemical class COCC[O-] ASQUQUOEFDHYGP-UHFFFAOYSA-N 0.000 description 1
- UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical compound C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 description 1
- ZUXNHFFVQWADJL-UHFFFAOYSA-N 3,4,5-trimethoxy-n-(2-methoxyethyl)-n-(4-phenyl-1,3-thiazol-2-yl)benzamide Chemical compound N=1C(C=2C=CC=CC=2)=CSC=1N(CCOC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 ZUXNHFFVQWADJL-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- QUQFOCUZYFFOBK-UHFFFAOYSA-N N-phenyl-2H-1,2-benzothiazine-3-carboxamide Chemical class S1NC(=CC2=C1C=CC=C2)C(=O)NC1=CC=CC=C1 QUQFOCUZYFFOBK-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- WACQKHWOTAEEFS-UHFFFAOYSA-N cyclohexane;ethyl acetate Chemical compound CCOC(C)=O.C1CCCCC1 WACQKHWOTAEEFS-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- WPPDXAHGCGPUPK-UHFFFAOYSA-N red 2 Chemical compound C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=2C=3C4=CC=C5C6=CC=C7C8=C(C=9C=CC=CC=9)C9=CC=CC=C9C(C=9C=CC=CC=9)=C8C8=CC=C(C6=C87)C(C=35)=CC=2)C4=C1C1=CC=CC=C1 WPPDXAHGCGPUPK-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
P,C, (Ph) 6341 SYNTHETIC METHOD AND
INTERMEDIATE FOR PIROXICAM
Abstract 2-Methoxyethyl 4-hydroxy-2-methyl-2H-1,2-benzothia-zine-3-carboxylate 1,1-dioxide is an advantageous ester precursor fpr piroxicam (4-hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxidel, an antiinflammatory agent established in medical practice.
INTERMEDIATE FOR PIROXICAM
Abstract 2-Methoxyethyl 4-hydroxy-2-methyl-2H-1,2-benzothia-zine-3-carboxylate 1,1-dioxide is an advantageous ester precursor fpr piroxicam (4-hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxidel, an antiinflammatory agent established in medical practice.
Description
~. a~
~1.~
Sy~THETIC ~ETEI(3P AND
~ENTER~EPIATE ~OR PI~ROXI:C:A~
T~,s ~n~enti~on. i,s concerned wi~t~.'2~m~th~xy~thyl 4-hydroxy~2~me.t~yl~2H~1,2~enzoth~azi,ne..~3-car~oxylat~ .
l,l-dioxlde.,', 0~ 0 ~C~C}I3 CI
~NCEI`3 O
an ester ha~ing spec~.al value. ~n t~ synthesis of pirox;,cam C4-hydroxy-2-methyl-N~2~pyr~dyl~2H~1~2-benzo~
thiaz~ne-3-car~oxamide 1,l-d~ox~de~
~f \ I OEI2 _. S~Nc~3 H
O O
an antiinflammatory agent of estabIished value in the medicinal art. It ~ill be noted that in past practice, the acyl rad;cal of compounds of this type has been sometimes written as O O
~'~
Q
and s~ch.compoun,d~s. ~lte~na,t~ e.ly na,m,e~ ~ 3,4~d~d~o-
~1.~
Sy~THETIC ~ETEI(3P AND
~ENTER~EPIATE ~OR PI~ROXI:C:A~
T~,s ~n~enti~on. i,s concerned wi~t~.'2~m~th~xy~thyl 4-hydroxy~2~me.t~yl~2H~1,2~enzoth~azi,ne..~3-car~oxylat~ .
l,l-dioxlde.,', 0~ 0 ~C~C}I3 CI
~NCEI`3 O
an ester ha~ing spec~.al value. ~n t~ synthesis of pirox;,cam C4-hydroxy-2-methyl-N~2~pyr~dyl~2H~1~2-benzo~
thiaz~ne-3-car~oxamide 1,l-d~ox~de~
~f \ I OEI2 _. S~Nc~3 H
O O
an antiinflammatory agent of estabIished value in the medicinal art. It ~ill be noted that in past practice, the acyl rad;cal of compounds of this type has been sometimes written as O O
~'~
Q
and s~ch.compoun,d~s. ~lte~na,t~ e.ly na,m,e~ ~ 3,4~d~d~o-
2~et~ 4-oxo~2x-l~2~enzot~azl~ne ~ di~oxi~de~deri~
: tives~ Those's~i~lled ~n th.e.'art w~ll understand tha,t ~,, ~2~
the~e. ar~ e.qui~ya,len,t taj~tome~ c ~ o~ the ~a~e.
compo~nd. The'present i~nYenti~on ls. ~,ntended tq e~co~p~ss both.tautomer,ic $orms w~ ,i,ti~n~ only one of the~
as a matter o~ conVen.i,ence~
~i~oxica~ was ori:gInally dtsclo~ed by ~om~ardino CU~S~ Patent 3,'5~1,584~t One o~ t~e processes ~or the synthesis~ o~ pirox~cam d~sclosed th.erein is to react a 3-carboxyl.c ac,~,d este~ ~t~ 2-am~nopyr~d~,ne, ~ore spec~ficall~, th.e ester ~s d~sclosed as a CCl-C121alkyl, ester or phenyl.CCl~c3~al~yl ester~ The specif~,c ester - described is t~e met~l,ester, yi,z~
OH O
I ll CH
O ~ 3. ~II
0~
~See also Lombardino e~ al., J. ~ed. Chem. 14, pp, 1171-1175 ~1971)]. A d;sad~antage in this ot~erwise useful process for piroxicam lies ln the varia~le formation of quantities of ~ highly colored byproduct. This highly colored byproduct, whic~ is removed only by multiple recrystallizations with major product loss, lends an unaccepta~le, strong yello~ color to the piroxicam bulk product, even when present at ~ery.low levels (e.g., 0.5-1%). This byproduct has been isolated and determined to have the following structure:
~NH~
O O
It ha's~ ~een $hown tha't ~ s ~ctually formed ~s ~
~yproduct in the re~ction, rather than being de~ved from . ~3~
a contaminant in t~e. pre.cursor. How this compound is actually formed in. the reaction mi~xture is not ~ully understood, although ~ethod$ wh;~.c~.are. directed to rap~d remoyal. o~ t~.e.me.thanol ~yproduct as ~it is for~ed in. t~e react~on appea~ tQ reduce the incidence o~
piroxicam ~atches ha:ving unaccepta~le. color, ~o~e.yer !
these methods are o~ uncertai~n dependaB~l~t~ and a goal has been to ~ind an ester ~h~ch Xs readily aya~
able by synt~esIs and w~:c~.does not gi:ye rise to an ether such as ~IVl as ~ troubleso~e.Byproduct durin.g conversion to p~ro~icam.
Alternative syntheses o~ piroxicam which have been disclosed in the literature. ~nclude reaction of 3,4-dihydro-2-methyl~4-oxo-2H-1,2-ben~.othtazine 1,1~
dioxide w;th 2-pyridyl isocyanate ~ombardino~ U,S.
Patent 3,5~1,5841 ! transam;dation of 4~hydroxy-2-methyl~
2H-1,2-benzothiazine-3-carboxanilides ~ith 2-aminopyridine (Lom~ardino, ~.S Patent 3,8~1,637~, cyclization of -~ CO ~ -C ~ lk 1 W 5O2NC ~CON~
20 (lombardino, U.S. Patent 3,853,B6~, coupling of a ~
4-(Cl-C3)alkoxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid l,l-dioxide with 2-aminopyridine followed by hydrolysis of the enol;c ether linkage (Lombardino U.S~
Patent 3,892,740)r couplin~ of 4~hydroxy~2-~ethyl~2H~
1,2-benzothiazine~3-carboxylic ac7 d, yia the. aCIa c~lQride, wit~.2~aminPpyr;di~ne~ enl ~S~ ~a~çnt 4~0Q~347~_ an.d methylati~.on.~ 4=hydr.ox~-N~2-.px~ dyl~2H~1,2~.BenzQtA~i~az~l~n~
: tives~ Those's~i~lled ~n th.e.'art w~ll understand tha,t ~,, ~2~
the~e. ar~ e.qui~ya,len,t taj~tome~ c ~ o~ the ~a~e.
compo~nd. The'present i~nYenti~on ls. ~,ntended tq e~co~p~ss both.tautomer,ic $orms w~ ,i,ti~n~ only one of the~
as a matter o~ conVen.i,ence~
~i~oxica~ was ori:gInally dtsclo~ed by ~om~ardino CU~S~ Patent 3,'5~1,584~t One o~ t~e processes ~or the synthesis~ o~ pirox~cam d~sclosed th.erein is to react a 3-carboxyl.c ac,~,d este~ ~t~ 2-am~nopyr~d~,ne, ~ore spec~ficall~, th.e ester ~s d~sclosed as a CCl-C121alkyl, ester or phenyl.CCl~c3~al~yl ester~ The specif~,c ester - described is t~e met~l,ester, yi,z~
OH O
I ll CH
O ~ 3. ~II
0~
~See also Lombardino e~ al., J. ~ed. Chem. 14, pp, 1171-1175 ~1971)]. A d;sad~antage in this ot~erwise useful process for piroxicam lies ln the varia~le formation of quantities of ~ highly colored byproduct. This highly colored byproduct, whic~ is removed only by multiple recrystallizations with major product loss, lends an unaccepta~le, strong yello~ color to the piroxicam bulk product, even when present at ~ery.low levels (e.g., 0.5-1%). This byproduct has been isolated and determined to have the following structure:
~NH~
O O
It ha's~ ~een $hown tha't ~ s ~ctually formed ~s ~
~yproduct in the re~ction, rather than being de~ved from . ~3~
a contaminant in t~e. pre.cursor. How this compound is actually formed in. the reaction mi~xture is not ~ully understood, although ~ethod$ wh;~.c~.are. directed to rap~d remoyal. o~ t~.e.me.thanol ~yproduct as ~it is for~ed in. t~e react~on appea~ tQ reduce the incidence o~
piroxicam ~atches ha:ving unaccepta~le. color, ~o~e.yer !
these methods are o~ uncertai~n dependaB~l~t~ and a goal has been to ~ind an ester ~h~ch Xs readily aya~
able by synt~esIs and w~:c~.does not gi:ye rise to an ether such as ~IVl as ~ troubleso~e.Byproduct durin.g conversion to p~ro~icam.
Alternative syntheses o~ piroxicam which have been disclosed in the literature. ~nclude reaction of 3,4-dihydro-2-methyl~4-oxo-2H-1,2-ben~.othtazine 1,1~
dioxide w;th 2-pyridyl isocyanate ~ombardino~ U,S.
Patent 3,5~1,5841 ! transam;dation of 4~hydroxy-2-methyl~
2H-1,2-benzothiazine-3-carboxanilides ~ith 2-aminopyridine (Lom~ardino, ~.S Patent 3,8~1,637~, cyclization of -~ CO ~ -C ~ lk 1 W 5O2NC ~CON~
20 (lombardino, U.S. Patent 3,853,B6~, coupling of a ~
4-(Cl-C3)alkoxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid l,l-dioxide with 2-aminopyridine followed by hydrolysis of the enol;c ether linkage (Lombardino U.S~
Patent 3,892,740)r couplin~ of 4~hydroxy~2-~ethyl~2H~
1,2-benzothiazine~3-carboxylic ac7 d, yia the. aCIa c~lQride, wit~.2~aminPpyr;di~ne~ enl ~S~ ~a~çnt 4~0Q~347~_ an.d methylati~.on.~ 4=hydr.ox~-N~2-.px~ dyl~2H~1,2~.BenzQtA~i~az~l~n~
3-car~oxa~i~e. (~anad~ ~atent 1,~g,8g:.4~ t Anot~er e~ter.xelated to t~e me.thoxyethyl ester o~ the present invention w~i~c~ Ra`s been speci~ically described ~n .~'7.
~4 the lIterature. i:s ethyl 4~h~droxy~2~methyl.~2H-1,2~benzo~
t.h~az~ne-3-carhoxy~late~ l,.l-d~oxIde. CRa,s~u~en,. .U.S.
Patent 3750.1,466i s~e. ~l~o Z~nnes et ~ls! U~t P~tent 3~816~8~s , .
, - .
~5~
The 2~met~oxyet~1 estex ~,I, ~as ~een synthe~ized.
In the.known proces,s o~ con~ertl`ng a corresponding 3n car~oxyli~c aci,d este~ to pirox~,cam, t~s ester has been su~sti,tuted ~or t~e.'pr,~or axt ~e~yl este~ , Use o~ t~e noveI este~ C~ ~as tfi~ surpr~sI,n~ advanta,ge that the p-'rox~,cam so produced conta;'ns no detecta~le le~el of the. expected,.~;ghly~colored eth.e~ ~yproduct I4~ ~
methoxyethoxyL~2-~ethyl~N-2~p~ridyl-2H~1,2 ~enzothiazine-3-cax~oxamide~, of t~e ~ormula CH2C~20CH3 ~
~ N -~ ~NCH~ H ' ~Y
O Oanalogous to the ether ~IV~', ~6.~
Deta~;led Desc~ t~on o~ the InYention T~e. ~qu;~red 2~met~sx~ethyl estex QIL is xea,dily prepaxed fro~ sacch~n-2~a,cetate ester I2_~eth~x~ethyl~
3~oxo-2H;~l~2-~enz~,sot~'azol~n2-2~aceta,te l,l~d~oxide, formula C~ y~ th.e.'$ollo~,i,ng sequenc~ o~ re~ct~o~s ~NC~I2COOCX~CH20CH3 ~b-3~ EYIl C}~30C~2C}~2o 1 ~e~rraDgement OH
~COOcH2cH20cH3 L~JII 1 ~NE
O O, methylation , ~ r ~COOCH2CH20CH3 O O
The rearrange~ent ~,~ ca~r~ed out by t~e~t~ng t~e intermediate saccha,~ n,-2~a~ceti~,c ac,~d e~tex ~t~
alkoxide, p~e~e~a,~ly a~ 2~-~thoxy~thox~de s~ch. ~s sod~um 2-methsx~e.thQx,i~d~ ~n orde., to .a,Vo~ e compli~cat,~,on o~ trans~es~tex~ cat,i.on.~ in a polar organic solyent such'as d,i~et~l sulfox~de or dl~et~
formamide., ~eth~lat~,on ~s accompl ,s~èd By a met~.~lat~n~
agent, suc~ as dimet~yl sulfate or a methyl halide, ,,t7~ 3,,3 ~7~
conyen~entl~ ~ethyl ,i~od,i~da~ ~n a react~on~i~e~t s~lyent such.'as a lower ke.ton,e.,,a lowex alkanolr fo~a~ide,~
d.imethyl~o~m~,id~ o~ m,~t~yl~ul~Qxi~de~
The~'sacc~ar,i,n,-2~acet',ic ac~d ester re.s~Ixed a~
sta~t~ng ma,te~i~al in th.e~ ab~ye'~se~uence~ is prepared ~ro~
saccha~in and 2~me.thoxye.th.yl c~Ioroacetate ~n ana,log~
to the method for preparation o~ the c~rrespond~,ng met~yl ester IChemIsc~e ~erichte.3Q, pç 1267. a8~7~, or, less~ dIrectly~ ydrolysl's o~ sa.~d me.thyl ester to the corresponding saccharin acetic ac~d and couplin~, such as Via the acid c~lor~de~ w.ith 2 methoxyethanol, The reaction o the methoxy ester CIl W~th 2~.amino~
pyrid;ne to produ~e piroxicam, - OH O ~ -= N~ N ~I~, .. ~ Y
- C~
15 is generally conducted by mixing the two components together in a reaction-inert solvent system at or near room temperature, and t~en heating the resultant system at 115-175 C. for a period of about one-hal to several hours. Although it is only necessary that these two reactants be present in substantially equimolar amounts in oraer to effect the reaction, a slight excess of one . or the other (,and preferably the more readily available - amine base reagentl is not harmful in this respect and may even serve to sh;ft the ammonolys.is re~cti~n to completion.. Pre~exred ~eactiQn~inert organ~,c ~olyent~
for use in the. a~m,on~lys,~s- ~eaction i~nc~de ~c~ lo~er N~N-dial~yl~lka~n.a~i,des as dime.th.~ r~amide~ di~ç.t~
aceta~,i.de and the li~ke.., a~s; ~ell ~ such.`aro~at~c ~ydro~
carbons solvents as Be`nzene~, toluene, ~ylene. and so ~orth, ~8 In any eyent,,~,t ~s ~ound ~QSt ~elp~ul ~nd usu~
~suitaBle.to d;~st~ll o~ t~e vo:L~t~le. alcohol. b~product as i~t ~ or~ed ~n the'~ea,ct~on ~nd thereB~ shi~t the ammonolysi~s equi~ r~um to comple-tion i~n th~s ~anner.
In the. pre ent instanc~, t~,e ~,st hi~hIy pre~er~ed sol~ent ~s xylene,' si~n,ce ~yproduct 2-~et~oxyet~anol ~s effici~ently remo~ed as a lower boil~ng azeotrope. The volume o~ xylene can ~e ma~nta:'~ned By the ~dd~tion of more'xylene during dist~,llattone After removal of the alcohol and complett,on o~ tfi.e. reacti.on t the resultIng piroxicam is con~eniently recovered by cooling and simple f~ltrat~on of the crystall~zed product~ If desired, the piroxicam ~s recrystalli.zed from d~met~ylacetamide~
acetone/water.
The present in~ention ~,s illustrated by the follow;ng examples., ~owever, it should be understood that -the invention i~s not lim~ted to the specific details of these. examples.
r-~
EX~qPI.
~4 the lIterature. i:s ethyl 4~h~droxy~2~methyl.~2H-1,2~benzo~
t.h~az~ne-3-carhoxy~late~ l,.l-d~oxIde. CRa,s~u~en,. .U.S.
Patent 3750.1,466i s~e. ~l~o Z~nnes et ~ls! U~t P~tent 3~816~8~s , .
, - .
~5~
The 2~met~oxyet~1 estex ~,I, ~as ~een synthe~ized.
In the.known proces,s o~ con~ertl`ng a corresponding 3n car~oxyli~c aci,d este~ to pirox~,cam, t~s ester has been su~sti,tuted ~or t~e.'pr,~or axt ~e~yl este~ , Use o~ t~e noveI este~ C~ ~as tfi~ surpr~sI,n~ advanta,ge that the p-'rox~,cam so produced conta;'ns no detecta~le le~el of the. expected,.~;ghly~colored eth.e~ ~yproduct I4~ ~
methoxyethoxyL~2-~ethyl~N-2~p~ridyl-2H~1,2 ~enzothiazine-3-cax~oxamide~, of t~e ~ormula CH2C~20CH3 ~
~ N -~ ~NCH~ H ' ~Y
O Oanalogous to the ether ~IV~', ~6.~
Deta~;led Desc~ t~on o~ the InYention T~e. ~qu;~red 2~met~sx~ethyl estex QIL is xea,dily prepaxed fro~ sacch~n-2~a,cetate ester I2_~eth~x~ethyl~
3~oxo-2H;~l~2-~enz~,sot~'azol~n2-2~aceta,te l,l~d~oxide, formula C~ y~ th.e.'$ollo~,i,ng sequenc~ o~ re~ct~o~s ~NC~I2COOCX~CH20CH3 ~b-3~ EYIl C}~30C~2C}~2o 1 ~e~rraDgement OH
~COOcH2cH20cH3 L~JII 1 ~NE
O O, methylation , ~ r ~COOCH2CH20CH3 O O
The rearrange~ent ~,~ ca~r~ed out by t~e~t~ng t~e intermediate saccha,~ n,-2~a~ceti~,c ac,~d e~tex ~t~
alkoxide, p~e~e~a,~ly a~ 2~-~thoxy~thox~de s~ch. ~s sod~um 2-methsx~e.thQx,i~d~ ~n orde., to .a,Vo~ e compli~cat,~,on o~ trans~es~tex~ cat,i.on.~ in a polar organic solyent such'as d,i~et~l sulfox~de or dl~et~
formamide., ~eth~lat~,on ~s accompl ,s~èd By a met~.~lat~n~
agent, suc~ as dimet~yl sulfate or a methyl halide, ,,t7~ 3,,3 ~7~
conyen~entl~ ~ethyl ,i~od,i~da~ ~n a react~on~i~e~t s~lyent such.'as a lower ke.ton,e.,,a lowex alkanolr fo~a~ide,~
d.imethyl~o~m~,id~ o~ m,~t~yl~ul~Qxi~de~
The~'sacc~ar,i,n,-2~acet',ic ac~d ester re.s~Ixed a~
sta~t~ng ma,te~i~al in th.e~ ab~ye'~se~uence~ is prepared ~ro~
saccha~in and 2~me.thoxye.th.yl c~Ioroacetate ~n ana,log~
to the method for preparation o~ the c~rrespond~,ng met~yl ester IChemIsc~e ~erichte.3Q, pç 1267. a8~7~, or, less~ dIrectly~ ydrolysl's o~ sa.~d me.thyl ester to the corresponding saccharin acetic ac~d and couplin~, such as Via the acid c~lor~de~ w.ith 2 methoxyethanol, The reaction o the methoxy ester CIl W~th 2~.amino~
pyrid;ne to produ~e piroxicam, - OH O ~ -= N~ N ~I~, .. ~ Y
- C~
15 is generally conducted by mixing the two components together in a reaction-inert solvent system at or near room temperature, and t~en heating the resultant system at 115-175 C. for a period of about one-hal to several hours. Although it is only necessary that these two reactants be present in substantially equimolar amounts in oraer to effect the reaction, a slight excess of one . or the other (,and preferably the more readily available - amine base reagentl is not harmful in this respect and may even serve to sh;ft the ammonolys.is re~cti~n to completion.. Pre~exred ~eactiQn~inert organ~,c ~olyent~
for use in the. a~m,on~lys,~s- ~eaction i~nc~de ~c~ lo~er N~N-dial~yl~lka~n.a~i,des as dime.th.~ r~amide~ di~ç.t~
aceta~,i.de and the li~ke.., a~s; ~ell ~ such.`aro~at~c ~ydro~
carbons solvents as Be`nzene~, toluene, ~ylene. and so ~orth, ~8 In any eyent,,~,t ~s ~ound ~QSt ~elp~ul ~nd usu~
~suitaBle.to d;~st~ll o~ t~e vo:L~t~le. alcohol. b~product as i~t ~ or~ed ~n the'~ea,ct~on ~nd thereB~ shi~t the ammonolysi~s equi~ r~um to comple-tion i~n th~s ~anner.
In the. pre ent instanc~, t~,e ~,st hi~hIy pre~er~ed sol~ent ~s xylene,' si~n,ce ~yproduct 2-~et~oxyet~anol ~s effici~ently remo~ed as a lower boil~ng azeotrope. The volume o~ xylene can ~e ma~nta:'~ned By the ~dd~tion of more'xylene during dist~,llattone After removal of the alcohol and complett,on o~ tfi.e. reacti.on t the resultIng piroxicam is con~eniently recovered by cooling and simple f~ltrat~on of the crystall~zed product~ If desired, the piroxicam ~s recrystalli.zed from d~met~ylacetamide~
acetone/water.
The present in~ention ~,s illustrated by the follow;ng examples., ~owever, it should be understood that -the invention i~s not lim~ted to the specific details of these. examples.
r-~
EX~qPI.
4-~2 Methoxye.thoxy~L~2~methyl-N~2-pyri~yl~2 1~2-benzc~th~azine~3~carBo~amide lrl~D~i.oxi.de ~o4-~(2-~ethoxye.th~l~piroxicama In a flame dried .~las~ ma~rlta.~.ned ~nde~ a~ dr~
nitrogen atmo~sp~ere~ p~i~rox~cam Q,814 g~ 5~47 mmolesL
was dissolved in 13~ o~ dr~ cli~m~thyl~or~ami`de~ Sod~um ~ydr~de. ~.131 g.., 5..47 mmolesl ~as added ~lo~.ly in porti.ons and th.e. result~ng mtxtu~e heated ~t 4Q~45Q C, for a~out 3 hours~ until suc~ time as t~e sodi.um h~dr;de had completely reacted. .2~ethoxyet~yl c~loride Ll ~ O ml ~, 0.94 mmolesl and sodiu~ ~od~de C~.821 g., 5~47 mmolesL
were then added and the reaction t~en heated at 8~ C.
for 51 hours. The cooled reaction mixture ~as di.luted with.a~out 5Q g. of ic~ and extracted with f~e 10 ml.
portions o~ methylene chloride~ The organic extracts were combined, ~ack-washed ~ith seven lS ml. portions of water, was~ed once with ~r;ne, dried over anhydrous magnesium sulfate, ~;:ltered and evaporated to an oil (I.44 g.~. The o~l was triturated with ether, yielding .soltds (.Q. 84 g~ 1 f which were recrystallized from acetonitrile CYielding 0.57 g.~. Recrystallized product ; (0.45 g.) was chromatographed on silica gel (13.5 g.), eluting with 2:3;6 methanol:cyclohexane;ethyl acetate and monitoring by TLC (same eluant~ with phosphomolybdic spray. Early cuts, containing clean product, were combined, evaporated in vacuo to solids. The solids were chased with. car~on tetrachloride and dried under high vacuum yielding O4~t2 methoxyethyl~piroxica~, ~0.31 g.; m.p. 155~15.7 C,; -~ Q.5 f2~3:~ methanolic~clo~
hexane;ethyl ace.tateI; R~ ~4 aQ;4;3 xylen.e;~tha.nol;
wateL~; Rn~rfCDC13~1delta 3.1~ 3El~, 3.35. (-s( 3HL~
3. 68 (~ 2H)! ~5.,23, ~ 2H.)~ 7 2 (~ lH~.r 7.~.C~, ~f 8.9: (~, 2H.)r 1~.2 (~road s, lH~ 5 ~ r~
~ 0~.
EX~MPI.E 2 2-Me ~ e._hyl 2~ChIoroacetate ~ ainta;~ni~ng a tempera~ture.o$ r~5 to 5 C-r 2~chloro-acetyl chIor~de. (11~2 g~ a,la 1~ole~. ~n 15 ml~ o~
meth~lene chlor~de was added dropw~i.se~o~çr 1 hou~ to a cold solution of p~ri.~ne C8.a.g~ Q.ll moleL and 2~methoxyethan.ol a.6 g,, Q:.lO ~oleI in 35 ~1~ o~
meth~lene chIoride. T~e Xeaction m~xture wa$ st~xred ~or a further 1 hour ~t ao C~r~ warmed to room temper~tuxe and extracted with.t~o 5~ ml~ port~ons of water~ The two asueous extracts were com~ined and ~ac~washed with. 50 ml.
of chloro~orm. The origInal organic layer and chloroform back-wash were comb~ned and was~ed w.ith 5Q ml~ o~ 5%
copper sulfate. The 5% copper sulfate wash was backwashed with 25 ml. of chloro$orm and recombined wit~ the organic phase. Finally, the organic phase was washed w~th. 50 ml.
of br~ne, treated w~t~ activated car~on and anhydrous magnesium sulate, ~iltered, concentrated to an oil and distilled to yield 2-met~oxyethyl 2-chloroacetate (14.1 g.; b.p. 80-82 C,~.
.
'71 ~
~11~
EX~LE 3 2~.Me.thoxy~th~l 3~0~o~2H~1~2~Benz~,~,othi,a,zol~ne.
2~ace.t~te, l~ D;~.oxide.
('2-Metho~y~tn~l Sa~cchari:n-2~acetateL
''''''''''~VI`~'''''' .. .. . . ... . .
Sod~,um sacchaxin a8 ~., o.a88 moleL and 2..~et~oxy~.
et~l 2-chloroacetate'Q3~'4 s.V'Q.Q88 ~ole.) were com~ined ~n 40. ml. o~ a~methyl~or~a~ide'and ~.eated at'l2Q C. Xor 4 ~ours. T~e react~on.~xture was cooled to 25q C~
lQ poured ~nto lOa ml. o~ w~ter, ~ranulated ~t 5~1Q C.
for Q.5 hour, filtered ,~t~ w~ter ~as~ and air d~ed to y~eld 2-methoxyeth~l sacc~ar;n-2~acetate I23.2 g., 90~; m.p. ~ 2 C.; mfe 2~9; irGKBrI 2~85 cm`'l~.
nl2.~
EX~$;~LE 4 2-.M~thoxyethyl 4~Hydroxy-2H~i't2~
' benzothi:azine--3icar:iox~late 1, l~di:oxide ~ , . .
Under a d~ n.~'trogen at~osphere, 2-~eth.o.x~ethanol Q2.,~. ml~ 9.24 mole~ wa~ charged to a stlrred, fla,me-dried flask... Sod,i,u~ sph.ere~, Q~.6 ~ ! .Q-4~3 ~ale.~
pentane wasA.ed and ,sl g~t'l~ 1attened wi,th'tweezex~L
were adde.d portionwise'o~er 2 ~ours, keeping the te~
perature of the react,~Qn m,~xture ~n t~.e xan~e o~
25-45 C~ ~fter an add~i~t,i,onal 1 hour o~ st~r~ngt ~
fuxther }0 ml. of 2~met~oxyethanol was added and the xeaction m~xture warmed to 57 C~ On sl;ght cooling the react~on mixture sol;d~f~ed~ The reactlon ~ixture ~as thinned wi~ 75 ml. o$ dr~ dImet~ylsul~oxide and a s~ngle remaining particle of sod;um metal removed mechanically.
The 2-methoxyethyl s~ccharin-2-acetate C50 ~., 0~.167 mole~
in 7Q ml. of warm, dry d~methylsuloxide w~s added dropwise oyer 20 minutes. The reaction m~xture was stirred..for 1 ~our at ambient temperature~ ~uenched into ~ mixture of concentrated hydrochlor~.c acid ~276 ml.~
and water ~1.84 1.~, maintaining the temperature of the quench at 20-25 C. ~y an ice-water bath and rate of addition. The slurry was granulated at 6-8 C. for 1 hour, filtered wit~ cold water wash and dried in air to yield 2-methoxyethyl 4-hydroxy-2H-1,2-benzoth~azine-3-carboxylate l,l-dioxide r32.8 g., 66~; m~p. 120-122 C.;
ir(KBr) 3448, 3226 cm 13.
~13~
EXA~L,E 5 2~ethDxyethyl 4-Hydroxy~2~met~yl~2H~ 2 ~enzoth~,azine.-3-c~rb~xylate l!l-Di~o~ide.
. ..
; 2-~et~ox~ethyl 4-hydroxy~2Hrl~2-~enzoth~a~z~ne~
3-car~oxylate. l~l~di~ox,id~. BI~I y., a~ 1~35 m,ol~ was com~ned with'23Q. ml. o~ ac~tone and cooled to lQ C~
Methyl ,~,od,~,de. ~21.9 ~ .155 mole.~ wa~ added~ followed b~ t~e drop~,se add~,tion~. ~Ver lQ ~nutes,. o~ sod,,u~
hydroxid~ Q0.3~5 ml.. o~ lM~. Th~ cooling ~a,th.~as ~emoyed and the ~eact~,on mI.xtux~ allowed to ~1Q~1Y ~r~ to room temperature Ca.~out 45 m~nutes~, then heated at 35 C, for 2 hours and f;nally at 3g-40~ C. for 16 hour~ The reaction mi.xture. was cooled to room temperature, diiuted with 20a ml. of aceto~e, treated w,it~ act~vated carbon, filtered and concentrated ;n vacuo at Q-~ C. to about 50 ml. ~he resulting slurry ~as ~lteFed~ and solids washed w;th ice-water and then dried in vacuo to yield 2-meth,oxyethyl 4~hydroxy~2~met~y1~2H-1,2 ~enzoth~azine~
3-car~oxylate l,l-d;ox~de ~2~.26 g., 9,0~; mOp. lQ6 lQ7.5 C.; mfe 313; ir(KBr~ 3345, 2941, 1684, 1351, 1053 cm l]o ;
~14~
EX~PLE 6 4~Hyd~oxy 2~ethyl-N-2-pyridyl~2~ 2-~enzoth~,azi~ne-3-carbQxamide l~l~D ,i,ox~,d~
.(P~rox~cam~
- - '''G~
2,~athoxyethyl 4~hxdxo~y~2~ 2-~enzoth ,az~ine~3 carBoxylate'l,l-dioxide L28 y~ a8~ mole~ and 2~am,~no~
p~r~d~ne C~26 g.,,O:.Og8 mole.~. ~eXe. com~ined ~th~
, 50.0 ml. of xylene'in ~ 1 liter ~lask e~uip~ed w~th.an add;tion ~unnel and a re~lux, variable take~off d~sti,l~
lation ~ead~ T~e. stirred react~on m~xture was heated to xe~lux and th.e xylene di.stilled at the rate o$
approximatel 1~0 ml~hour, while ma;~ntaining t~e pot volume almost constant by t~.e. addît~on o~ ~resh ~lene.
After 6 ho~rs, the ~ead temperature, which had been relatively constant at 134Q C~ rose to 142 C, and reflux rate slowed~ The reaction mixture was then cooled in an ice-bath.and the precipitated sol~ds ~ecovered by ~iltrat~on, w~th hexane for transfer and wash! and dried at 45 C. in vacuo to yi,eld pirox~.cam ~28.5 g., 96~;
m.p. 167-174 C.),. This product was examined by high performance liquid chromatography using 60:4Q 0.1~
Na2HPO4 adjusted to pH 7.5 wit~ citric acid;methanol ; on Micro-Bonda pak C18 Crrademark of Waters Associates 25 for a standard hplc column packing consisting of s;loxy subst~tuted silica coated on micro-glass ~eads.~ Under the conditions employed, piroxicam has a retention time of about 6 minutes,~whereas the potential contaminant, O -methoxyethylpiroxicam, has a retention time of 16.5 m;nutes. None o~ the.potential contaminant was de.tected in the. product o$ t~e p~esent Exa~pl~.
For pu,r,poses of recrysta,lli~ation~ e a~.,oye pirox~cam c25 ~..L was ~a~en u~ n lgQ ml~ o~ d~e,.t ~ l~
ace.ta,m,i~de at 70~75~ C~, treated w~i,t~.1.26. ~: o~ a~ct~yated ca,r~on at 75'-80~ C~ and fi~lte~ed throug~'di~atomaceous .
.a~
~15-.
e~xth wi~th 55 ml~ o~ war~ d~ethyl~ce.ta.~idQ ~or trans~er and wash. ~ m;xture.o$ 173 ~1. o~ a,cet~ne. a,nd 173 ml.
of ~ater was cooled to.5~ C!, THe car~on~treated ~ltrate was added slowly oyer lQ.-15 ~.nutes to t~e c~I,lled a.que.ou,s~ ace.tone.~' and tli.e ~esult~n~ crystal$
granulated at 0.-5 C~ ~or 5 m;nutes,. Rec~sta,ll;zed piroxicam was reco~ered ~ ~iltrat~on .~,it~ 154 ml~ of cold met~an~ ~for trans~er and was~. YIeld,' 18~75 g~ f 75%; ~r(:n~ l mull~ ident~cal ~r~,t~ aut~entic piroxicamt e r~,~a r ~
nitrogen atmo~sp~ere~ p~i~rox~cam Q,814 g~ 5~47 mmolesL
was dissolved in 13~ o~ dr~ cli~m~thyl~or~ami`de~ Sod~um ~ydr~de. ~.131 g.., 5..47 mmolesl ~as added ~lo~.ly in porti.ons and th.e. result~ng mtxtu~e heated ~t 4Q~45Q C, for a~out 3 hours~ until suc~ time as t~e sodi.um h~dr;de had completely reacted. .2~ethoxyet~yl c~loride Ll ~ O ml ~, 0.94 mmolesl and sodiu~ ~od~de C~.821 g., 5~47 mmolesL
were then added and the reaction t~en heated at 8~ C.
for 51 hours. The cooled reaction mixture ~as di.luted with.a~out 5Q g. of ic~ and extracted with f~e 10 ml.
portions o~ methylene chloride~ The organic extracts were combined, ~ack-washed ~ith seven lS ml. portions of water, was~ed once with ~r;ne, dried over anhydrous magnesium sulfate, ~;:ltered and evaporated to an oil (I.44 g.~. The o~l was triturated with ether, yielding .soltds (.Q. 84 g~ 1 f which were recrystallized from acetonitrile CYielding 0.57 g.~. Recrystallized product ; (0.45 g.) was chromatographed on silica gel (13.5 g.), eluting with 2:3;6 methanol:cyclohexane;ethyl acetate and monitoring by TLC (same eluant~ with phosphomolybdic spray. Early cuts, containing clean product, were combined, evaporated in vacuo to solids. The solids were chased with. car~on tetrachloride and dried under high vacuum yielding O4~t2 methoxyethyl~piroxica~, ~0.31 g.; m.p. 155~15.7 C,; -~ Q.5 f2~3:~ methanolic~clo~
hexane;ethyl ace.tateI; R~ ~4 aQ;4;3 xylen.e;~tha.nol;
wateL~; Rn~rfCDC13~1delta 3.1~ 3El~, 3.35. (-s( 3HL~
3. 68 (~ 2H)! ~5.,23, ~ 2H.)~ 7 2 (~ lH~.r 7.~.C~, ~f 8.9: (~, 2H.)r 1~.2 (~road s, lH~ 5 ~ r~
~ 0~.
EX~MPI.E 2 2-Me ~ e._hyl 2~ChIoroacetate ~ ainta;~ni~ng a tempera~ture.o$ r~5 to 5 C-r 2~chloro-acetyl chIor~de. (11~2 g~ a,la 1~ole~. ~n 15 ml~ o~
meth~lene chlor~de was added dropw~i.se~o~çr 1 hou~ to a cold solution of p~ri.~ne C8.a.g~ Q.ll moleL and 2~methoxyethan.ol a.6 g,, Q:.lO ~oleI in 35 ~1~ o~
meth~lene chIoride. T~e Xeaction m~xture wa$ st~xred ~or a further 1 hour ~t ao C~r~ warmed to room temper~tuxe and extracted with.t~o 5~ ml~ port~ons of water~ The two asueous extracts were com~ined and ~ac~washed with. 50 ml.
of chloro~orm. The origInal organic layer and chloroform back-wash were comb~ned and was~ed w.ith 5Q ml~ o~ 5%
copper sulfate. The 5% copper sulfate wash was backwashed with 25 ml. of chloro$orm and recombined wit~ the organic phase. Finally, the organic phase was washed w~th. 50 ml.
of br~ne, treated w~t~ activated car~on and anhydrous magnesium sulate, ~iltered, concentrated to an oil and distilled to yield 2-met~oxyethyl 2-chloroacetate (14.1 g.; b.p. 80-82 C,~.
.
'71 ~
~11~
EX~LE 3 2~.Me.thoxy~th~l 3~0~o~2H~1~2~Benz~,~,othi,a,zol~ne.
2~ace.t~te, l~ D;~.oxide.
('2-Metho~y~tn~l Sa~cchari:n-2~acetateL
''''''''''~VI`~'''''' .. .. . . ... . .
Sod~,um sacchaxin a8 ~., o.a88 moleL and 2..~et~oxy~.
et~l 2-chloroacetate'Q3~'4 s.V'Q.Q88 ~ole.) were com~ined ~n 40. ml. o~ a~methyl~or~a~ide'and ~.eated at'l2Q C. Xor 4 ~ours. T~e react~on.~xture was cooled to 25q C~
lQ poured ~nto lOa ml. o~ w~ter, ~ranulated ~t 5~1Q C.
for Q.5 hour, filtered ,~t~ w~ter ~as~ and air d~ed to y~eld 2-methoxyeth~l sacc~ar;n-2~acetate I23.2 g., 90~; m.p. ~ 2 C.; mfe 2~9; irGKBrI 2~85 cm`'l~.
nl2.~
EX~$;~LE 4 2-.M~thoxyethyl 4~Hydroxy-2H~i't2~
' benzothi:azine--3icar:iox~late 1, l~di:oxide ~ , . .
Under a d~ n.~'trogen at~osphere, 2-~eth.o.x~ethanol Q2.,~. ml~ 9.24 mole~ wa~ charged to a stlrred, fla,me-dried flask... Sod,i,u~ sph.ere~, Q~.6 ~ ! .Q-4~3 ~ale.~
pentane wasA.ed and ,sl g~t'l~ 1attened wi,th'tweezex~L
were adde.d portionwise'o~er 2 ~ours, keeping the te~
perature of the react,~Qn m,~xture ~n t~.e xan~e o~
25-45 C~ ~fter an add~i~t,i,onal 1 hour o~ st~r~ngt ~
fuxther }0 ml. of 2~met~oxyethanol was added and the xeaction m~xture warmed to 57 C~ On sl;ght cooling the react~on mixture sol;d~f~ed~ The reactlon ~ixture ~as thinned wi~ 75 ml. o$ dr~ dImet~ylsul~oxide and a s~ngle remaining particle of sod;um metal removed mechanically.
The 2-methoxyethyl s~ccharin-2-acetate C50 ~., 0~.167 mole~
in 7Q ml. of warm, dry d~methylsuloxide w~s added dropwise oyer 20 minutes. The reaction m~xture was stirred..for 1 ~our at ambient temperature~ ~uenched into ~ mixture of concentrated hydrochlor~.c acid ~276 ml.~
and water ~1.84 1.~, maintaining the temperature of the quench at 20-25 C. ~y an ice-water bath and rate of addition. The slurry was granulated at 6-8 C. for 1 hour, filtered wit~ cold water wash and dried in air to yield 2-methoxyethyl 4-hydroxy-2H-1,2-benzoth~azine-3-carboxylate l,l-dioxide r32.8 g., 66~; m~p. 120-122 C.;
ir(KBr) 3448, 3226 cm 13.
~13~
EXA~L,E 5 2~ethDxyethyl 4-Hydroxy~2~met~yl~2H~ 2 ~enzoth~,azine.-3-c~rb~xylate l!l-Di~o~ide.
. ..
; 2-~et~ox~ethyl 4-hydroxy~2Hrl~2-~enzoth~a~z~ne~
3-car~oxylate. l~l~di~ox,id~. BI~I y., a~ 1~35 m,ol~ was com~ned with'23Q. ml. o~ ac~tone and cooled to lQ C~
Methyl ,~,od,~,de. ~21.9 ~ .155 mole.~ wa~ added~ followed b~ t~e drop~,se add~,tion~. ~Ver lQ ~nutes,. o~ sod,,u~
hydroxid~ Q0.3~5 ml.. o~ lM~. Th~ cooling ~a,th.~as ~emoyed and the ~eact~,on mI.xtux~ allowed to ~1Q~1Y ~r~ to room temperature Ca.~out 45 m~nutes~, then heated at 35 C, for 2 hours and f;nally at 3g-40~ C. for 16 hour~ The reaction mi.xture. was cooled to room temperature, diiuted with 20a ml. of aceto~e, treated w,it~ act~vated carbon, filtered and concentrated ;n vacuo at Q-~ C. to about 50 ml. ~he resulting slurry ~as ~lteFed~ and solids washed w;th ice-water and then dried in vacuo to yield 2-meth,oxyethyl 4~hydroxy~2~met~y1~2H-1,2 ~enzoth~azine~
3-car~oxylate l,l-d;ox~de ~2~.26 g., 9,0~; mOp. lQ6 lQ7.5 C.; mfe 313; ir(KBr~ 3345, 2941, 1684, 1351, 1053 cm l]o ;
~14~
EX~PLE 6 4~Hyd~oxy 2~ethyl-N-2-pyridyl~2~ 2-~enzoth~,azi~ne-3-carbQxamide l~l~D ,i,ox~,d~
.(P~rox~cam~
- - '''G~
2,~athoxyethyl 4~hxdxo~y~2~ 2-~enzoth ,az~ine~3 carBoxylate'l,l-dioxide L28 y~ a8~ mole~ and 2~am,~no~
p~r~d~ne C~26 g.,,O:.Og8 mole.~. ~eXe. com~ined ~th~
, 50.0 ml. of xylene'in ~ 1 liter ~lask e~uip~ed w~th.an add;tion ~unnel and a re~lux, variable take~off d~sti,l~
lation ~ead~ T~e. stirred react~on m~xture was heated to xe~lux and th.e xylene di.stilled at the rate o$
approximatel 1~0 ml~hour, while ma;~ntaining t~e pot volume almost constant by t~.e. addît~on o~ ~resh ~lene.
After 6 ho~rs, the ~ead temperature, which had been relatively constant at 134Q C~ rose to 142 C, and reflux rate slowed~ The reaction mixture was then cooled in an ice-bath.and the precipitated sol~ds ~ecovered by ~iltrat~on, w~th hexane for transfer and wash! and dried at 45 C. in vacuo to yi,eld pirox~.cam ~28.5 g., 96~;
m.p. 167-174 C.),. This product was examined by high performance liquid chromatography using 60:4Q 0.1~
Na2HPO4 adjusted to pH 7.5 wit~ citric acid;methanol ; on Micro-Bonda pak C18 Crrademark of Waters Associates 25 for a standard hplc column packing consisting of s;loxy subst~tuted silica coated on micro-glass ~eads.~ Under the conditions employed, piroxicam has a retention time of about 6 minutes,~whereas the potential contaminant, O -methoxyethylpiroxicam, has a retention time of 16.5 m;nutes. None o~ the.potential contaminant was de.tected in the. product o$ t~e p~esent Exa~pl~.
For pu,r,poses of recrysta,lli~ation~ e a~.,oye pirox~cam c25 ~..L was ~a~en u~ n lgQ ml~ o~ d~e,.t ~ l~
ace.ta,m,i~de at 70~75~ C~, treated w~i,t~.1.26. ~: o~ a~ct~yated ca,r~on at 75'-80~ C~ and fi~lte~ed throug~'di~atomaceous .
.a~
~15-.
e~xth wi~th 55 ml~ o~ war~ d~ethyl~ce.ta.~idQ ~or trans~er and wash. ~ m;xture.o$ 173 ~1. o~ a,cet~ne. a,nd 173 ml.
of ~ater was cooled to.5~ C!, THe car~on~treated ~ltrate was added slowly oyer lQ.-15 ~.nutes to t~e c~I,lled a.que.ou,s~ ace.tone.~' and tli.e ~esult~n~ crystal$
granulated at 0.-5 C~ ~or 5 m;nutes,. Rec~sta,ll;zed piroxicam was reco~ered ~ ~iltrat~on .~,it~ 154 ml~ of cold met~an~ ~for trans~er and was~. YIeld,' 18~75 g~ f 75%; ~r(:n~ l mull~ ident~cal ~r~,t~ aut~entic piroxicamt e r~,~a r ~
Claims (3)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for converting an ester of the formula to piroxicam which comprises reacting said ester with 2-aminopyridine in a reaction-inert organic solvent at 115-175°C.
until the reaction is substantially complete.
until the reaction is substantially complete.
2. A process of claim 1 wherein the solvent is xylene.
3. A process of claim 1 or 2 wherein byproduct 2-methoxyethanol is removed by codistillation with solvent during the reaction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000445578A CA1181749A (en) | 1980-09-29 | 1984-01-18 | Process for the preparation of 2-methoxyethyl 4- hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/191,716 US4289879A (en) | 1980-09-29 | 1980-09-29 | Synthetic method and intermediate for piroxicam |
US191,716 | 1980-09-29 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000445578A Division CA1181749A (en) | 1980-09-29 | 1984-01-18 | Process for the preparation of 2-methoxyethyl 4- hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1171413A true CA1171413A (en) | 1984-07-24 |
Family
ID=22706653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000386690A Expired CA1171413A (en) | 1980-09-29 | 1981-09-25 | Synthetic method and intermediate for piroxicam |
Country Status (30)
Country | Link |
---|---|
US (1) | US4289879A (en) |
EP (1) | EP0049099B1 (en) |
JP (2) | JPS5788172A (en) |
KR (1) | KR850000923B1 (en) |
AR (1) | AR228373A1 (en) |
AU (1) | AU528125B2 (en) |
CA (1) | CA1171413A (en) |
CS (1) | CS228520B2 (en) |
DD (1) | DD202151A5 (en) |
DE (1) | DE3171404D1 (en) |
DK (1) | DK148232C (en) |
EG (1) | EG16103A (en) |
ES (1) | ES8206518A1 (en) |
FI (1) | FI72719C (en) |
GR (1) | GR75772B (en) |
GT (1) | GT198171634A (en) |
HK (1) | HK52287A (en) |
HU (1) | HU186785B (en) |
IE (1) | IE51598B1 (en) |
IL (1) | IL63938A0 (en) |
MY (1) | MY8700511A (en) |
NO (1) | NO158061C (en) |
NZ (1) | NZ198475A (en) |
PH (1) | PH18475A (en) |
PL (1) | PL130042B1 (en) |
PT (1) | PT73738B (en) |
SG (1) | SG23187G (en) |
SU (1) | SU1122224A3 (en) |
YU (1) | YU42428B (en) |
ZA (1) | ZA816706B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4434164A (en) | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Crystalline benzothiazine dioxide salts |
IN158333B (en) * | 1981-08-03 | 1986-10-18 | Pfizer | |
GT198276334A (en) * | 1981-08-03 | 1984-01-10 | PROCEDURE AND INTER-MEDIA FOR THE PRODUCTION OF BENZOTIAZINE CARBOXAMIDES. | |
US4376204A (en) * | 1981-10-05 | 1983-03-08 | Pfizer Inc. | 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam |
IN159273B (en) * | 1981-10-05 | 1987-04-25 | Pfizer | |
CA1197244A (en) * | 1982-04-16 | 1985-11-26 | Medichem, S.A. | Process for the preparation of 4-hydroxy-2-methyl-2h- 1,2-benzothiazine-3-carboxamide-1,1-dioxides |
SU1306476A3 (en) * | 1982-06-17 | 1987-04-23 | Пфайзер,Инк (Фирма) | Method for producing 2-methyl-3-n-(2-pyridyl)-carbamoyl-3,4-dihydro-2h-1,2-benzthiazine-1,1-dioxide |
EP0098422B1 (en) * | 1982-07-07 | 1987-12-09 | Siegfried Aktiengesellschaft | Process for preparing 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
IT1153293B (en) * | 1982-10-22 | 1987-01-14 | Francia Famaceutici S R L | DERIVATIVES OF 4-HYDROXY-2-METHYL-2H-1, 2-BENZOTHIAZINE-3-CARBOSSAMIDE 1, 1-DIOXIDE AND PROCEDURE FOR THEIR PREPARATION |
FI72317C (en) * | 1983-10-06 | 1987-05-11 | Pfizer | PROCEDURE FOR THE FRAMEWORK OF PHARMACEUTICALS 2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZINE-1,1-DIOXIDE -3- (N-2-PYRIDYL)-CARBOXAMIDE |
WO1987006933A1 (en) * | 1986-05-16 | 1987-11-19 | Pfizer Inc. | Benzothiazine dioxide derivatives |
ES2002646A6 (en) * | 1987-03-27 | 1988-09-01 | Induspol Sa | Process for obtaining 4-hydroxy-2-methyl-N-(2-piridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide. |
WO1989003682A1 (en) * | 1987-10-26 | 1989-05-05 | Pfizer Inc. | Benzothiazine dioxide derivatives |
FR2942797B1 (en) * | 2009-03-03 | 2011-04-29 | Pf Medicament | BENZOTHIAZINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3501466A (en) * | 1967-11-30 | 1970-03-17 | Mcneilab Inc | 3-carbamoyl and 3-alkoxycarbonyl benzothiazine-1,1-dioxides |
US3591584A (en) * | 1968-08-27 | 1971-07-06 | Pfizer | Benzothiazine dioxides |
US3787324A (en) * | 1971-03-01 | 1974-01-22 | Warner Lambert Co | 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production |
US3853862A (en) * | 1973-04-23 | 1974-12-10 | Pfizer | Production of 4-hydroxy-1,2-benzothiazine-3-carboxamides |
US4074048A (en) * | 1976-05-10 | 1978-02-14 | Warner-Lambert Company | Process for the preparation of 4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides |
-
1980
- 1980-09-29 US US06/191,716 patent/US4289879A/en not_active Expired - Lifetime
-
1981
- 1981-09-23 DE DE8181304370T patent/DE3171404D1/en not_active Expired
- 1981-09-23 EP EP81304370A patent/EP0049099B1/en not_active Expired
- 1981-09-23 EG EG541/81A patent/EG16103A/en active
- 1981-09-25 GT GT198171634A patent/GT198171634A/en unknown
- 1981-09-25 YU YU2309/81A patent/YU42428B/en unknown
- 1981-09-25 CA CA000386690A patent/CA1171413A/en not_active Expired
- 1981-09-25 IL IL63938A patent/IL63938A0/en not_active IP Right Cessation
- 1981-09-25 IE IE2233/81A patent/IE51598B1/en not_active IP Right Cessation
- 1981-09-25 AR AR286875A patent/AR228373A1/en active
- 1981-09-28 KR KR1019810003626A patent/KR850000923B1/en active
- 1981-09-28 PT PT73738A patent/PT73738B/en not_active IP Right Cessation
- 1981-09-28 JP JP56153540A patent/JPS5788172A/en active Granted
- 1981-09-28 DD DD81233629A patent/DD202151A5/en not_active IP Right Cessation
- 1981-09-28 PL PL1981233212A patent/PL130042B1/en unknown
- 1981-09-28 SU SU813338298A patent/SU1122224A3/en active
- 1981-09-28 CS CS817107A patent/CS228520B2/en unknown
- 1981-09-28 GR GR66142A patent/GR75772B/el unknown
- 1981-09-28 NZ NZ198475A patent/NZ198475A/en unknown
- 1981-09-28 ES ES505851A patent/ES8206518A1/en not_active Expired
- 1981-09-28 NO NO813290A patent/NO158061C/en unknown
- 1981-09-28 DK DK428781A patent/DK148232C/en not_active IP Right Cessation
- 1981-09-28 HU HU812792A patent/HU186785B/en not_active IP Right Cessation
- 1981-09-28 ZA ZA816706A patent/ZA816706B/en unknown
- 1981-09-28 AU AU75698/81A patent/AU528125B2/en not_active Ceased
- 1981-09-28 FI FI813003A patent/FI72719C/en not_active IP Right Cessation
- 1981-09-29 PH PH26285A patent/PH18475A/en unknown
-
1985
- 1985-11-06 JP JP60248694A patent/JPS61112064A/en active Granted
-
1987
- 1987-03-09 SG SG231/87A patent/SG23187G/en unknown
- 1987-07-09 HK HK522/87A patent/HK52287A/en unknown
- 1987-12-30 MY MY511/87A patent/MY8700511A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1171413A (en) | Synthetic method and intermediate for piroxicam | |
EP2855467B1 (en) | Processes to produce certain 2-(pyridine-3-yl)thiazoles | |
CA1067079A (en) | Nitrogen-containing heterobicyclic compounds | |
EP2855466B1 (en) | Processes to produce certain 2-(pyridine-3-yl)thiazoles | |
KR100222309B1 (en) | Substituted 2-acylamino-5-thiazole, their preparation and pharmaceutical composition containing them | |
CA2137976A1 (en) | Thienothiazine derivatives | |
CZ196693A3 (en) | Thiazolidinedione derivatives, and process for preparing thereof | |
JPH06345724A (en) | Cyano compound and its production | |
WO1996020936A1 (en) | Novel thiazolidin-4-one derivatives | |
FI79319C (en) | Process for the preparation of novel therapeutically useful tricyclic a oxindol carboxamide derivatives | |
US4684658A (en) | Anti-thrombotic ortho-condensed pyrrole derivatives, compositions, and method of use therefor | |
CA2120395A1 (en) | Thiazolopyrimidine derivatives | |
AU2013272006A1 (en) | Processes to produce certain 2-(pyridine-3-yl)thiazoles | |
US4090020A (en) | Thienothiazine derivatives | |
JP3440196B2 (en) | Method for producing thiobenzamide derivative | |
NL8300304A (en) | SUBSTITUTED 1,3,4-THIADIAZOLO3,2-A PYRIMIDINES AND METHOD FOR THE PREPARATION THEREOF. | |
HU196215B (en) | Process for producing pyrrolo-thiazoles | |
HU194199B (en) | Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents | |
KR850001223B1 (en) | Process for preparing piroxicam and intermediates leading thereto | |
Nagarapu et al. | Synthesis of phenylimidazo thiazolo benzocycloheptene derivatives as potential antiinflammatory agent-IV | |
US4376204A (en) | 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam | |
KR20020087835A (en) | Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof | |
CA1181749A (en) | Process for the preparation of 2-methoxyethyl 4- hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide | |
EP0146102A2 (en) | Process for preparing benzothiazine compounds | |
EP0440319A1 (en) | Process and intermediates for the preparation of annelated iminothiazoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEC | Expiry (correction) | ||
MKEX | Expiry |